CD4 and COVID-19: It was reported that SARS-CoV-2-specific CD4+ T cells were increased in patients with severe COVID-19, but these cells displayed low functional avidity and clonality in severe cases than those in mild cases (110), which should be investigated to acquire a better understanding of the underlying mechanisms in future studies.